Idorsia Ltd
SIX:IDIA
Idorsia Ltd
Cash from Investing Activities
Idorsia Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Idorsia Ltd
SIX:IDIA
|
Cash from Investing Activities
CHf743.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Cash from Investing Activities
-$3.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Cash from Investing Activities
CHf65.6m
|
CAGR 3-Years
32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Cash from Investing Activities
$374.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Cash from Investing Activities
-CHf1m
|
CAGR 3-Years
69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
30%
|
|
Kuros Biosciences AG
SIX:KURN
|
Cash from Investing Activities
-CHf326k
|
CAGR 3-Years
-14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
See Also
What is Idorsia Ltd's Cash from Investing Activities?
Cash from Investing Activities
743.9m
CHF
Based on the financial report for Dec 31, 2022, Idorsia Ltd's Cash from Investing Activities amounts to 743.9m CHF.